Increased risk of renal impairment, hyperkalemia, and hypotension Generally avoid concomitant use; monitor BP, renal function, and electrolytes if used concomitantly Aliskiren Increased risk of renal impairment, hyperkalemia, and hypotension Generally avoid concomitant use; monitor BP, renal function, ...
Aceclofenac The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Aceclofenac. Acemetacin The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Acemetacin. Acenocoumarol ...
Hyperkalemia (high potassium in the blood) may occur in certain people receiving this medicine. Check with your doctor right away if you have stomach pain, confusion, irregular heartbeat, nausea or vomiting, nervousness, numbness or tingling in the hands, feet, or lips, trouble breathing, or ...
Heparins A lesser known adverse reaction to heparins is hyperkalemia (Edes and Sunderrajan, 1985); thus, it may enhance the hyperkalemic effect of valsartan C Levodopa Levodopa can reduce blood pressure, resulting in hypotension (Senard et al., 1995); thus, it can increase the effects of ...
Reduced Risk of Hyperkalemia Using Sacubitril/Valsartan vs EnalaprilAkshay S. DesaiOrly VardenyBrian ClaggettJohn J. V. McMurrayMilton PackerKarl SwedbergJean L. RouleauMichael R. ZileMartin LefkowitzVictor Shi
The impact of potassium binders on mortality in patients with hyperkalemia: a single-center study. Kidney Dial. 2023;3(3):244-254. doi:10.3390/kidneydial3030022 Google ScholarCrossref 44. Butler J, Anker SD, Lund LH, et al. Patiromer for the management of hype...
Diovan has been evaluated for safety in 290 pediatric patients aged 1 to less than 6 years and over 400 patients aged 6 to 17 years. No relevant differences were identified between the adverse experience profile for pediatric patients and that previously reported for adult patients. Hyperkalemia wa...
High Potassium Level (Hyperkalemia).Valsartan can cause a high potassium level (hyperkalemia), which can be serious and may lead to death. Your healthcare provider will check your potassium levels, especially if you take certain other medicines. Call your healthcare provider if you have any of ...
If oligohydramnios is observed, consider alternative therapy; closely observe neonates with histories of in utero exposure to the drug for hypotension, oliguria, and hyperkalemia; in neonates with a history of in utero exposure to the drug, if oliguria or hypotension occurs, support BP and renal...
However, he said, the rate of hyperkalemia was higher in the sacubitril/valsartan group (17% vs. 9%;P= .035). At 24 weeks, there was no difference between the groups in CV death or HF hospitalization (HR = 1.32; 95% CI, 0.86-2.03;P= .2) or HF hospitalization (HR ...